Because this journey isnt about losing joy
Thats why the FDAs own technical staff has recommended against expanded access, and the public health group Partnership for Safe Medicines calls them "popular, unproven, dangerous. As Peter Kolchinsky, managing partner of biotech investor RA Capital Management, puts it: Is the FDA going to stand on science or is it going to permit all kinds of snake oil to be readily available? The FDA meeting will last two days
Im going to walk you through the mechanistic differences, clinical evidence, metabolic outcomes, and practical considerations that actually matter in the Retatrutide vs Cagrilintide debate
These signals enhance mitochondrial fitness, restore redox homeostasis, attenuate pro-inflammatory glycolysis, and stabilize endothelial-pericyte coupling to stabilize a permissive neurorehabilitation microenvironment
K.VlkolinskyR.et al (2023)